Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Alemtuzumab by Sanofi for T-Cell Leukemia: Likelihood of Approval
Alemtuzumab is under clinical development by Sanofi and currently in Phase I for T-Cell Leukemia. According to GlobalData, Phase I...